3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Leukemia
1
Carcinoma, Medullary
1
Advanced Cancer
1
Interventions
vandetanib
10
selpercatinib
5
cabozantinib
4
pralsetinib
3
yeast-CEA vaccine
1
rovalpituzumab tesirine
1
motesanib diphosphate
1
anlotinib
1
Sorafenib
1
Ranitidine
1
Omeprazole
1
Melphalan
1
Dexamethasone
1
Calcium Aluminosilicate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
Carcinoma, Medullary
×
Ranitidine
×
Clear all
NCT01539655
2017-05-02
Vandetanib
Sanofi
Phase 1
Completed
34 enrolled